BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11125201)

  • 1. Diverse activity spectra of bacteriocin-like inhibitory substances having activity against mutans streptococci.
    Balakrishnan M; Simmonds RS; Tagg JR
    Caries Res; 2001; 35(1):75-80. PubMed ID: 11125201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevention of dental caries by BLIS-mediated inhibition of mutans streptococci.
    James SM; Tagg JR
    N Z Dent J; 1991 Jul; 87(389):80-3. PubMed ID: 1956623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of bacteriocin-like substances by human oral streptococci.
    Fabio U; Bondi M; Manicardi G; Messi P; Neglia R
    Microbiologica; 1987 Oct; 10(4):363-70. PubMed ID: 3695984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro bacteriocin-mediated antagonism by oral streptococci against human carrier strains of staphylococci.
    Tzannetis SE; Bigis A; Konidaris N; Ioannidis H; Genimatas V; Papavassiliou J
    J Appl Bacteriol; 1991 Apr; 70(4):294-301. PubMed ID: 2055791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Tagg JR
    Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of oolong tea extract on caries-inducing properties of mutans streptococci.
    Matsumoto M; Minami T; Sasaki H; Sobue S; Hamada S; Ooshima T
    Caries Res; 1999; 33(6):441-5. PubMed ID: 10529529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.
    Minami M; Ohmori D; Tatsuno I; Isaka M; Kawamura Y; Ohta M; Hasegawa T
    FEMS Microbiol Lett; 2009 Sep; 298(1):67-73. PubMed ID: 19594623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between oral bacteria: inhibition of Streptococcus mutans bacteriocin production by Streptococcus gordonii.
    Wang BY; Kuramitsu HK
    Appl Environ Microbiol; 2005 Jan; 71(1):354-62. PubMed ID: 15640209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mutacin administration on Streptococcus mutans-induced dental caries in rats.
    Ooshima T; Yasufuku Y; Izumitani A; Sumi N; Iwanami T
    Microbiol Immunol; 1985; 29(12):1163-73. PubMed ID: 3831717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and Bacteriocin-Related Typing of
    Conrads G; Westenberger J; Lürkens M; Abdelbary MMH
    Front Cell Infect Microbiol; 2019; 9():110. PubMed ID: 31041198
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains.
    Shokri D; Zaghian S; Khodabakhsh F; Fazeli H; Mobasherizadeh S; Ataei B
    J Microbiol Immunol Infect; 2014 Oct; 47(5):371-6. PubMed ID: 23838264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different bacteriocin activities of Streptococcus mutans reflect distinct phylogenetic lineages.
    Balakrishnan M; Simmonds RS; Kilian M; Tagg JR
    J Med Microbiol; 2002 Nov; 51(11):941-948. PubMed ID: 12448678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of bacteriocin-like inhibitory substances from dochi-isolated Enterococcus faecium D081821 and D081833.
    Chen YS; Yanagida F; Srionnual S
    Lett Appl Microbiol; 2007 Mar; 44(3):320-5. PubMed ID: 17309511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoocin A and lauricidin in combination reduce Streptococcus mutans growth in a multispecies biofilm.
    Lester K; Simmonds RS
    Caries Res; 2012; 46(3):185-93. PubMed ID: 22508519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting effects of Enterococcus faecium non-biofilm strain on Streptococcus mutans biofilm formation.
    Kumada M; Motegi M; Nakao R; Yonezawa H; Yamamura H; Tagami J; Senpuku H
    J Microbiol Immunol Infect; 2009 Jun; 42(3):188-96. PubMed ID: 19812852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and properties of bacteriocin-like inhibitory substances from the swine pathogen Streptococcus suis serotype 2.
    Mélançon D; Grenier D
    Appl Environ Microbiol; 2003 Aug; 69(8):4482-8. PubMed ID: 12902232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Bowe WP; Filip JC; DiRienzo JM; Volgina A; Margolis DJ
    J Drugs Dermatol; 2006 Oct; 5(9):868-70. PubMed ID: 17039652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Bacteriocin-Like Inhibitory Substance (BLIS) from
    Kim NN; Kim BS; Lee HB; An S; Kim D; Kang SS
    Food Sci Anim Resour; 2022 Nov; 42(6):1020-1030. PubMed ID: 36415579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad.
    Tagg JR
    Probiotics Antimicrob Proteins; 2009 Jun; 1(1):60-6. PubMed ID: 26783132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of bacteriocins in Streptococcus mutans.
    Watanabe A; Kawada-Matsuo M; Le MN; Hisatsune J; Oogai Y; Nakano Y; Nakata M; Miyawaki S; Sugai M; Komatsuzawa H
    Sci Rep; 2021 Jun; 11(1):12963. PubMed ID: 34155274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.